Evidence map›Paper›PMID 39073749›Full record

ArticleProbiotics and antimicrobial proteins2025

Antagonistic Effects and the Underlying Mechanisms of Bacillus velezensis and its Antibacterial Peptide LCI Against Aeromonas hydrophila Infection in Largemouth Bass.

Xulu Chang, Lili Yun, Zhikun Liu, Yihao Shen, Shikun Feng, Guokun Yang, Xiaolin Meng

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Journal of bacteriology · 2026
    Review
  3. Genomic insights intoFrontiers in veterinary science · 2026
    Article
  4. Integrated Probiotic Benefits ofAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xulu ChangCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Lili YunCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Zhikun LiuCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Yihao ShenCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Shikun FengCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Guokun YangCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China.
Xiaolin MengCollege of Fisheries, Henan Normal University, Xinxiang, 453007, People's Republic of China. mengxiaolinqdio@126.com.

Funding

Key Technology Research Project of Henan Province 232102110114National Natural Science Foundation of China 32273149National Natural Science Foundation of China 32303020National Natural Science Foundation of China 32373155
6 · The paper itself

Abstract

Aeromonas hydrophila is one of the most prevalent pathogenic bacteria in largemouth bass. The use of antibiotics to inhibit A. hydrophila poses a significant threat to fish and environmental safety. Bacillus velezensis, a safe bacterium with probiotic and antibacterial characteristics, is an ideal candidate for antagonizing A. hydrophila. This study explored the antagonistic effects of B. velezensis FLU-1 on A. hydrophila in vivo and in vitro. In addition, we explored the antimicrobial peptides (AMPs) produced by strain FLU-1 and clarified the underlying antibacterial mechanisms. The results showed that strain FLU-1 could inhibit a variety of fish pathogens, including A. hydrophila. The challenge test showed that dietary supplementation with B. velezensis FLU-1 significantly improved the survival rate of largemouth bass and reduced the bacterial load in liver. Subsequently, the AMP LCI was isolated from B. velezensis FLU-1 and was found to be effective against A. hydrophila in vitro and in vivo. Transcriptomic analysis revealed that LCI downregulated the genes associated with flagellar assembly and peptidoglycan synthesis in A. hydrophila. Phenotypic test results showed that LCI disrupted the membrane integrity, markedly reduced the biofilm biomass and diminished the swimming motility of A. hydrophila. Furthermore, the results showed that LCI bound to the genomic DNA of A. hydrophila and destroyed the DNA structures. Overall, these findings elucidated the mechanism of action of LCI against A. hydrophila at the phenotypic and physiological levels. This study suggests that B. velezensis FLU-1 and its AMP LCI could serve as antibiotic alternatives for controlling pathogens in aquaculture.

Indexed as

Aeromonas hydrophilaAnti-Bacterial AgentsAntimicrobial PeptidesBacillusBassFish DiseasesGram-Negative Bacterial InfectionsProbioticsAnimalsBiofilmsAnti-Bacterial AgentsAntimicrobial PeptidesAeromonas hydrophilaAntibacterial mechanismAntimicrobial peptideBacillus velezensisLargemouth bass

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.